General Information
Drug ID
DR01257
Drug Name
Gadobenate dimeglumine
Synonyms
Multihance Multipack; Multihance; Gd-Bopta/dimeg; Gadobenate dimeglumine; Gadobenic acid dimeglumine salt; Gadobenate Dimeglumine [USAN]; B 1903617; Gadobenic acid; 127000-20-8; Dihydrogen ((+-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-))gadolinate(2-), compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
Drug Type
Small molecular drug
Indication CNS imaging [ICD11: XD47Y1] Approved [1]
Therapeutic Class
Contrast Media
Structure
3D MOL 2D MOL
Formula
C36H62GdN5O21
Canonical SMILES
[H+].[H+].CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
InChI
InChI=1S/C22H31N3O11.2C7H17NO5.Gd/c26-18(27)10-23(6-7-24(11-19(28)29)12-20(30)31)8-9-25(13-21(32)33)17(22(34)35)15-36-14-16-4-2-1-3-5-16;2*1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-5,17H,6-15H2,(H,26,27)(H,28,29)(H,30,31)(H,32,33)(H,34,35);2*4-13H,2-3H2,1H3;/q;;;+3/p-3/t;2*4-,5+,6+,7+;/m.00./s1
InChIKey
OCDAWJYGVOLXGZ-VPVMAENOSA-K
CAS Number
CAS 127000-20-8
Pharmaceutical Properties Molecular Weight 1058.1 Topological Polar Surface Area 446
Heavy Atom Count 63 Rotatable Bond Count 16
Hydrogen Bond Donor Count 14 Hydrogen Bond Acceptor Count 26
PubChem CID
24838350
PubChem SID
12014647 , 46506805 , 57371834 , 75285303 , 114787603 , 160964086
TTD Drug ID
D01OIL
DT(s) Transporting This Drug MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [2]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [2]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [2]
References
1 Gadobenate dimeglumine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes. Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):657-667.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.